Loading…

Novel pathways in the pathogenesis of respiratory syncytial virus disease

Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infections in infants and children. Extensive research in past decades has expanded our knowledge regarding the specific mechanisms involved in the pathogenesis of RSV bronchiolitis and subsequent chronic obstructive airway d...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric pulmonology 2000-08, Vol.30 (2), p.131-138
Main Authors: van Schaik, S.M., Welliver, R.C., Kimpen, J.L.L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4208-e4162032f5914e4a16a0a872ed8bdd954b322092e6afd2ae97ebf201d759d0123
container_end_page 138
container_issue 2
container_start_page 131
container_title Pediatric pulmonology
container_volume 30
creator van Schaik, S.M.
Welliver, R.C.
Kimpen, J.L.L.
description Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infections in infants and children. Extensive research in past decades has expanded our knowledge regarding the specific mechanisms involved in the pathogenesis of RSV bronchiolitis and subsequent chronic obstructive airway disease. Studies of RSV infection are performed in humans, cell culture models, and animal models, each with their own specific limitations. A recently developed murine model in which pulmonary dysfunction can be monitored and quantified appears to add a powerful tool for the study of specific pathogenic mechanisms of experimental RSV infections. Both immunologic and nonimmunologic factors have been implicated in the pathogenesis of RSV‐induced diseases. Recently, a hypothesis that RSV bronchiolitis may be the result of production of Th2‐type cytokines has become popular. There are, however, studies in human infants with RSV as well as in RSV‐infected mice that suggest this theory is incorrect, or at least an oversimplification. There is compelling evidence that cells producing interferon gamma may contribute to RSV‐induced wheezing, possibly through induction of leukotriene release. Among the nonimmunologic factors, pulmonary surfactant has recently attracted attention, especially because of the therapeutic implications for infants with severe bronchiolitis. A better understanding of the pathogenesis of RSV‐induced diseases will be of considerable help in developing specific therapeutic strategies and in vaccine development. Pediatr Pulmonol. 2000; 30:131–138. © 2000 Wiley‐Liss, Inc.
doi_str_mv 10.1002/1099-0496(200008)30:2<131::AID-PPUL8>3.0.CO;2-S
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71247894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71247894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4208-e4162032f5914e4a16a0a872ed8bdd954b322092e6afd2ae97ebf201d759d0123</originalsourceid><addsrcrecordid>eNqVkE1v00AQQFcIRNPCX0A-IEQPDvvlj00RUhUgjRQ1RaXKcbSxx3TBscOO0-J_z6aOCgcu-LLy6O3b0WMsE3wsOJfvBDcm5tqkbyUPX36q-ES-F0pMJufzj_HV1c0i_6DGfDxdnsn4-gkbPd54ykZ5liRxmqfqiB0TfQ8CY4x4zo4CJKVQyYjNL9s7rKOt7W7vbU-Ra6LuFh_-22_YIDmK2irySFvnbdf6PqK-KfrO2Tq6c35HUekILeEL9qyyNeHLw3nCbj5_-jq9iBfL2Xx6vogLLXkeoxap5EpWiREatRWp5TbPJJb5uixNotdKyrAeprYqpUWT4bqSXJRZYkoupDphbwbv1rc_d0gdbBwVWNe2wXZHkAmps9zoAC4HsPAtkccKtt5trO9BcNjXhX0r2LeCoS4oDmGqBECoCw91QQGH6TLMr4Px1eHp3XqD5V--IWcAXh8AS4WtK2-bwtEfTic6USpgXwbs3tXY_8da_9pqGARnPDgddfjr0Wn9D0gzlSWwupzBdLbSF2K1AKl-A0zorms</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71247894</pqid></control><display><type>article</type><title>Novel pathways in the pathogenesis of respiratory syncytial virus disease</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>van Schaik, S.M. ; Welliver, R.C. ; Kimpen, J.L.L.</creator><creatorcontrib>van Schaik, S.M. ; Welliver, R.C. ; Kimpen, J.L.L.</creatorcontrib><description>Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infections in infants and children. Extensive research in past decades has expanded our knowledge regarding the specific mechanisms involved in the pathogenesis of RSV bronchiolitis and subsequent chronic obstructive airway disease. Studies of RSV infection are performed in humans, cell culture models, and animal models, each with their own specific limitations. A recently developed murine model in which pulmonary dysfunction can be monitored and quantified appears to add a powerful tool for the study of specific pathogenic mechanisms of experimental RSV infections. Both immunologic and nonimmunologic factors have been implicated in the pathogenesis of RSV‐induced diseases. Recently, a hypothesis that RSV bronchiolitis may be the result of production of Th2‐type cytokines has become popular. There are, however, studies in human infants with RSV as well as in RSV‐infected mice that suggest this theory is incorrect, or at least an oversimplification. There is compelling evidence that cells producing interferon gamma may contribute to RSV‐induced wheezing, possibly through induction of leukotriene release. Among the nonimmunologic factors, pulmonary surfactant has recently attracted attention, especially because of the therapeutic implications for infants with severe bronchiolitis. A better understanding of the pathogenesis of RSV‐induced diseases will be of considerable help in developing specific therapeutic strategies and in vaccine development. Pediatr Pulmonol. 2000; 30:131–138. © 2000 Wiley‐Liss, Inc.</description><identifier>ISSN: 8755-6863</identifier><identifier>EISSN: 1099-0496</identifier><identifier>DOI: 10.1002/1099-0496(200008)30:2&lt;131::AID-PPUL8&gt;3.0.CO;2-S</identifier><identifier>PMID: 10922135</identifier><identifier>CODEN: PEPUES</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Animals ; Bacterial diseases ; Bacterial diseases of the respiratory system ; Biological and medical sciences ; bronchiolitis ; Bronchiolitis - physiopathology ; Child ; Child, Preschool ; cytokines ; Disease Models, Animal ; Human bacterial diseases ; Humans ; Infant ; Infant, Newborn ; Infectious diseases ; interferon gamma ; Leukotrienes - secretion ; Medical sciences ; Mice ; obstructive airway disease ; pulmonary surfactant ; Pulmonary Surfactants - metabolism ; Respiratory Sounds - etiology ; Respiratory Syncytial Virus Infections - immunology ; Respiratory Syncytial Virus Infections - physiopathology ; Respiratory Syncytial Virus, Human - immunology ; Respiratory Syncytial Virus, Human - pathogenicity ; viral respiratory infection</subject><ispartof>Pediatric pulmonology, 2000-08, Vol.30 (2), p.131-138</ispartof><rights>Copyright © 2000 Wiley‐Liss, Inc.</rights><rights>2000 INIST-CNRS</rights><rights>Copyright 2000 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4208-e4162032f5914e4a16a0a872ed8bdd954b322092e6afd2ae97ebf201d759d0123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1454533$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10922135$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Schaik, S.M.</creatorcontrib><creatorcontrib>Welliver, R.C.</creatorcontrib><creatorcontrib>Kimpen, J.L.L.</creatorcontrib><title>Novel pathways in the pathogenesis of respiratory syncytial virus disease</title><title>Pediatric pulmonology</title><addtitle>Pediatr. Pulmonol</addtitle><description>Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infections in infants and children. Extensive research in past decades has expanded our knowledge regarding the specific mechanisms involved in the pathogenesis of RSV bronchiolitis and subsequent chronic obstructive airway disease. Studies of RSV infection are performed in humans, cell culture models, and animal models, each with their own specific limitations. A recently developed murine model in which pulmonary dysfunction can be monitored and quantified appears to add a powerful tool for the study of specific pathogenic mechanisms of experimental RSV infections. Both immunologic and nonimmunologic factors have been implicated in the pathogenesis of RSV‐induced diseases. Recently, a hypothesis that RSV bronchiolitis may be the result of production of Th2‐type cytokines has become popular. There are, however, studies in human infants with RSV as well as in RSV‐infected mice that suggest this theory is incorrect, or at least an oversimplification. There is compelling evidence that cells producing interferon gamma may contribute to RSV‐induced wheezing, possibly through induction of leukotriene release. Among the nonimmunologic factors, pulmonary surfactant has recently attracted attention, especially because of the therapeutic implications for infants with severe bronchiolitis. A better understanding of the pathogenesis of RSV‐induced diseases will be of considerable help in developing specific therapeutic strategies and in vaccine development. Pediatr Pulmonol. 2000; 30:131–138. © 2000 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the respiratory system</subject><subject>Biological and medical sciences</subject><subject>bronchiolitis</subject><subject>Bronchiolitis - physiopathology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>cytokines</subject><subject>Disease Models, Animal</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infectious diseases</subject><subject>interferon gamma</subject><subject>Leukotrienes - secretion</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>obstructive airway disease</subject><subject>pulmonary surfactant</subject><subject>Pulmonary Surfactants - metabolism</subject><subject>Respiratory Sounds - etiology</subject><subject>Respiratory Syncytial Virus Infections - immunology</subject><subject>Respiratory Syncytial Virus Infections - physiopathology</subject><subject>Respiratory Syncytial Virus, Human - immunology</subject><subject>Respiratory Syncytial Virus, Human - pathogenicity</subject><subject>viral respiratory infection</subject><issn>8755-6863</issn><issn>1099-0496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqVkE1v00AQQFcIRNPCX0A-IEQPDvvlj00RUhUgjRQ1RaXKcbSxx3TBscOO0-J_z6aOCgcu-LLy6O3b0WMsE3wsOJfvBDcm5tqkbyUPX36q-ES-F0pMJufzj_HV1c0i_6DGfDxdnsn4-gkbPd54ykZ5liRxmqfqiB0TfQ8CY4x4zo4CJKVQyYjNL9s7rKOt7W7vbU-Ra6LuFh_-22_YIDmK2irySFvnbdf6PqK-KfrO2Tq6c35HUekILeEL9qyyNeHLw3nCbj5_-jq9iBfL2Xx6vogLLXkeoxap5EpWiREatRWp5TbPJJb5uixNotdKyrAeprYqpUWT4bqSXJRZYkoupDphbwbv1rc_d0gdbBwVWNe2wXZHkAmps9zoAC4HsPAtkccKtt5trO9BcNjXhX0r2LeCoS4oDmGqBECoCw91QQGH6TLMr4Px1eHp3XqD5V--IWcAXh8AS4WtK2-bwtEfTic6USpgXwbs3tXY_8da_9pqGARnPDgddfjr0Wn9D0gzlSWwupzBdLbSF2K1AKl-A0zorms</recordid><startdate>200008</startdate><enddate>200008</enddate><creator>van Schaik, S.M.</creator><creator>Welliver, R.C.</creator><creator>Kimpen, J.L.L.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200008</creationdate><title>Novel pathways in the pathogenesis of respiratory syncytial virus disease</title><author>van Schaik, S.M. ; Welliver, R.C. ; Kimpen, J.L.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4208-e4162032f5914e4a16a0a872ed8bdd954b322092e6afd2ae97ebf201d759d0123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the respiratory system</topic><topic>Biological and medical sciences</topic><topic>bronchiolitis</topic><topic>Bronchiolitis - physiopathology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>cytokines</topic><topic>Disease Models, Animal</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infectious diseases</topic><topic>interferon gamma</topic><topic>Leukotrienes - secretion</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>obstructive airway disease</topic><topic>pulmonary surfactant</topic><topic>Pulmonary Surfactants - metabolism</topic><topic>Respiratory Sounds - etiology</topic><topic>Respiratory Syncytial Virus Infections - immunology</topic><topic>Respiratory Syncytial Virus Infections - physiopathology</topic><topic>Respiratory Syncytial Virus, Human - immunology</topic><topic>Respiratory Syncytial Virus, Human - pathogenicity</topic><topic>viral respiratory infection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Schaik, S.M.</creatorcontrib><creatorcontrib>Welliver, R.C.</creatorcontrib><creatorcontrib>Kimpen, J.L.L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Schaik, S.M.</au><au>Welliver, R.C.</au><au>Kimpen, J.L.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel pathways in the pathogenesis of respiratory syncytial virus disease</atitle><jtitle>Pediatric pulmonology</jtitle><addtitle>Pediatr. Pulmonol</addtitle><date>2000-08</date><risdate>2000</risdate><volume>30</volume><issue>2</issue><spage>131</spage><epage>138</epage><pages>131-138</pages><issn>8755-6863</issn><eissn>1099-0496</eissn><coden>PEPUES</coden><abstract>Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infections in infants and children. Extensive research in past decades has expanded our knowledge regarding the specific mechanisms involved in the pathogenesis of RSV bronchiolitis and subsequent chronic obstructive airway disease. Studies of RSV infection are performed in humans, cell culture models, and animal models, each with their own specific limitations. A recently developed murine model in which pulmonary dysfunction can be monitored and quantified appears to add a powerful tool for the study of specific pathogenic mechanisms of experimental RSV infections. Both immunologic and nonimmunologic factors have been implicated in the pathogenesis of RSV‐induced diseases. Recently, a hypothesis that RSV bronchiolitis may be the result of production of Th2‐type cytokines has become popular. There are, however, studies in human infants with RSV as well as in RSV‐infected mice that suggest this theory is incorrect, or at least an oversimplification. There is compelling evidence that cells producing interferon gamma may contribute to RSV‐induced wheezing, possibly through induction of leukotriene release. Among the nonimmunologic factors, pulmonary surfactant has recently attracted attention, especially because of the therapeutic implications for infants with severe bronchiolitis. A better understanding of the pathogenesis of RSV‐induced diseases will be of considerable help in developing specific therapeutic strategies and in vaccine development. Pediatr Pulmonol. 2000; 30:131–138. © 2000 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10922135</pmid><doi>10.1002/1099-0496(200008)30:2&lt;131::AID-PPUL8&gt;3.0.CO;2-S</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 8755-6863
ispartof Pediatric pulmonology, 2000-08, Vol.30 (2), p.131-138
issn 8755-6863
1099-0496
language eng
recordid cdi_proquest_miscellaneous_71247894
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Bacterial diseases
Bacterial diseases of the respiratory system
Biological and medical sciences
bronchiolitis
Bronchiolitis - physiopathology
Child
Child, Preschool
cytokines
Disease Models, Animal
Human bacterial diseases
Humans
Infant
Infant, Newborn
Infectious diseases
interferon gamma
Leukotrienes - secretion
Medical sciences
Mice
obstructive airway disease
pulmonary surfactant
Pulmonary Surfactants - metabolism
Respiratory Sounds - etiology
Respiratory Syncytial Virus Infections - immunology
Respiratory Syncytial Virus Infections - physiopathology
Respiratory Syncytial Virus, Human - immunology
Respiratory Syncytial Virus, Human - pathogenicity
viral respiratory infection
title Novel pathways in the pathogenesis of respiratory syncytial virus disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A55%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20pathways%20in%20the%20pathogenesis%20of%20respiratory%20syncytial%20virus%20disease&rft.jtitle=Pediatric%20pulmonology&rft.au=van%20Schaik,%20S.M.&rft.date=2000-08&rft.volume=30&rft.issue=2&rft.spage=131&rft.epage=138&rft.pages=131-138&rft.issn=8755-6863&rft.eissn=1099-0496&rft.coden=PEPUES&rft_id=info:doi/10.1002/1099-0496(200008)30:2%3C131::AID-PPUL8%3E3.0.CO;2-S&rft_dat=%3Cproquest_cross%3E71247894%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4208-e4162032f5914e4a16a0a872ed8bdd954b322092e6afd2ae97ebf201d759d0123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71247894&rft_id=info:pmid/10922135&rfr_iscdi=true